If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | |||||||||
![]() Clinical & Experimental OphthalmologyVolume 34 Issue 5, Pages 472 - 484 Published Online: 12 Jul 2006 Journal Compilation © 2009 Royal Australian and New Zealand College of Ophthalmologists Published on behalf of the Royal Australian and New Zealand College of Ophthalmologists
Abstract | References | Full Text: HTML, PDF (Size: 221K) | Related Articles | Citation Tracking Perspective Complex genetics of complex traits: the case of primary open-angle glaucoma Copyright 2006 Royal Australian and New Zealand College of Ophthalmologists KEYWORDS association • cascade screening • glaucoma inheritance study in tasmania • myocilin • optineurin • single nucleotide polymorphism Abstract
Glaucoma, which is a complex heterogeneous disease, presents an ideal case for genetic investigation. Primary open-angle glaucoma (POAG) is the commonest subtype and will be the focus of this review. When detected early, POAG is amenable to therapeutic intervention. Unfortunately, current population-based clinical screening lacks efficacy. If individuals with a genetic predisposition for developing POAG can be identified, then efficient and cost-effective population-based screening programs could be designed. Although considerable inroads have been made in understanding the natural history of POAG caused by mutations in the myocilin and optineurin genes, other POAG genes accounting for most cases remain to be identified. This review explores the genetic mechanisms that have been unequivocally linked to the glaucomatous process and then discusses potential avenues for future breakthroughs. Received 19 January 2006; accepted 18 April 2006. |